ADMA Biologics: Premium Valuation Justified By Strong Fundamentals And Future Potential
ADMA Biologics' differentiated products and strong patent portfolio support continued growth despite premium valuation. Learn ...
Scientists Demonstrate Pre-clinical Proof of Concept for Next-Gen DNA Delivery Technology
Findings show potential for new lipid-based delivery formulations as a platform technology for immunizationPhiladelphia, PA, ...
一点资讯 on MSN16 小时
科研进展 | 华中农大在狂犬病疫苗研究上取得新进展
南湖新闻网讯（通讯员 邓嘉敏）近日，华中农业大学农业微生物资源发掘与利用全国重点实验室、纳米化学生物学团队韩鹤友教授课题组在 ACS Nano杂志上发表题为“Metal−Phenolic Network Hydrogel Vaccine ...
Frontiers2 天
Allergen-specific Antibodies: From Basic Science to Clinical Application
Type I allergy, an IgE antibody triggered hypersensitivity disease, represents a common public health problem affecting about one third of the world´s population. Upon exposure to allergens, IgE ...
Healio2 天
‘Giants’ to tackle primary immunodeficiencies for practicing physicians during conference
Primary immunodeficiencies are not as rare as they used to be, James Fernandez, MD, PhD, told Healio, and practicing ...
USA Today3 天
New York City officials report second measles case as Texas outbreak continues
"Vaccines not only protect individual children from measles but also contribute to community immunity, protecting those who are unable to be vaccinated due to medical reasons." The measles virus ...